The Army Reserve is set to lose 90% of its airpower, including units in Colorado Springs. The cuts are driven by Army ...
India: Researchers have found in a new study that calcium hydroxide remains a valuable intracanal medicament, with improved ...
Asianet Newsable on MSN
OKYO Pharma Stock Rises After Company Outlines Development Pathway For Neuropathic Corneal Pain Drug
Okyo announced on Monday that it is now focused on advancing to a multiple-ascending-dose clinical trial, designed to enroll ...
Suicidal ideation was reported by 13.2% of patients with atopic eczema compared with 8.5% of those without atopic eczema.
OKYO Pharma has announced its plans for the next stage of clinical development of urcosimod (formerly OK-101), its lead drug ...
OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to ...
OKYO Pharma (OKYO) announced plans for the next stage of clinical development for its lead drug candidate, urcosimod, to treat neuropathic corneal ...
In the heart of Houston stands a lime-green building that defies the laws of retail physics – a place where $39 can transform your entire closet and treasure hunters lose track of time as readily as ...
Experts writing in a medical journal are sounding the alarm about a little-known drug that's up to 20 times more deadly than ...
Z, Aaliyah, Madonna, Michael Jackson, Beyoncé, Rihanna and many more, Timbaland is one of the most influential and successful hitmakers of the last 35 years. His sound is often called futuristic, and ...
Atom Therapeutics has announced enrollment of the first patient in a Phase II trial (NCT07145229) for ABP-745, a novel ...
Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received a $17 million contract modification from the Biomedical Advanced Research and Development Authority (BARDA), part of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results